Search Within

Kevin Andrew David

Formats
  1. Meeting Abstract (11)
  2. Correspondence (1)
  3. Journal Article (1)
  4. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (13)
  2. Center for Hematologic Malignancies (12)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (12)
  4. Department of Medicine (12)
  5. GSK Faculty (12)
  6. Hematologic Malignancies Research (12)

More Groups

People
  1. Pallawi Torka (13)
  2. Alison Moskowitz (12)
  3. Andrew Intlekofer (12)
  4. Andrew Zelenetz (12)
  5. Anita Kumar (12)
  6. Ariela Noy (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (11)
Publications
  1. Blood (9)
  2. Hematological Oncology (2)
  3. Blood Cancer Journal (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Hematology & Oncology (1)
Publishers
  1. American Society of Hematology (9)
  2. Wiley Blackwell (2)
  3. American Society of Clinical Oncology (1)
  4. Biomed Central Ltd (1)
  5. Nature Publishing Group (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: A multicenter cohort study
    Correspondence

    Epperla, N.; Feng, L.; Shah, N. N.; Fitzgerald, L.; Shah, H.; Stephens, D. M.; Lee, C. J.; Ollila, T.; Shouse, G.; Danilov, A. V.; more...
    Journal of Hematology & Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save